Twist Bioscience Corporation Financial Ratios — TWST Stock

Profitability (USD)

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-73.17	-70.72	-71.12	-47.77	-27.63	-26.19	-23.55	-30.02	-12.37
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	-315.2	-123.09	-26.59	12.8	31.85	39.08	41.38	36.61	42.61	50.72
EBITDA Margin (%)	-1,737.64	-496.53	-254.97	-188.91	-123.09	-108.45	-114.22	-72.45	-46.16	-29.58
Operating Margin (%)	-1,924.02	-543.16	-277.5	-200.15	-130.5	-115.81	-122.33	-84.41	-56.2	-36.18
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	-1,943.06	-548.25	-279.21	-197.44	-154.88	-116.39	-112.14	-83.01	-66.51	-20.43
Profit Margin (%)	-1,943.06	-550.85	-280.16	-197.98	-155.31	-114.94	-107.02	-83.48	-66.69	-20.63
Net Income to Common Margin (%)	-1,943.06	-550.85	-280.16	-197.98	-155.31	-114.94	-107.02	-83.48	-66.69	-20.63
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API Chat

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	11	9	10	8	36	63	95	94	85	76
ST Debt	1	- -	2	3	10	10	14	15	15	14
LT Debt	10	9	7	4	26	53	81	79	70	62
Total Debt/EBITDA	-0.28	-0.17	-0.15	-0.08	-0.32	-0.44	-0.41	-0.53	-0.59	-0.68
Net Debt/EBITDA	0.44	0.41	1.1	0.38	0.8	3.24	1.63	1.61	1.57	1.64
Total Debt/EBIT	-0.26	-0.16	-0.14	-0.07	-0.31	-0.41	-0.38	-0.45	-0.48	-0.55
Net Debt/EBIT	0.4	0.38	1.01	0.36	0.76	3.03	1.52	1.38	1.29	1.34
EBITDA to Interest Expense	-52.85	-59.07	-49.38	-79.4	-140.92	-391.04	-2,906.34	-35,518.6	-4,981.69	- -
EBITDA-CapEx/Interest Expense	-61.2	-66.36	-52.19	-90.8	-153.46	-464.77	-4,179.55	-41,074.4	-5,156.72	- -
EBIT to Interest Expense	-58.52	-64.62	-53.74	-84.12	-149.4	-417.6	-3,112.76	-41,380.6	-6,065.55	- -
Interest Expense	1	1	1	1	1	- -	- -	- -	- -	- -
Common Equity/Total Assets	-105.03	-163	-182.1	-170.34	-114.93	-86.96	-86.17	-133.05	-202.16	-205.59
Long-Term Debt/Equity (%)	- -	- -	- -	2.89	7.8	9.15	10.3	12.7	14.86	13.06
Long-Term Debt/Capital (%)	-14.2	-7.02	-3.59	-1.42	-6.21	-9.71	-11.08	-8.43	-6.07	-4.96
Long-Term Debt/Total Assets (%)	12.83	10.69	6.23	2.35	6.58	7.57	8.45	10.2	11.43	9.62
Total Debt/Equity (%)	-14.59	-6.86	-4.82	5.08	10.7	10.83	12.02	15.09	17.99	15.98
Total Debt/Capital (%)	-16.17	-7.02	-4.83	-2.49	-8.52	-11.49	-12.94	-10.02	-7.35	-6.07
Total Debt/Total Assets (%)	14.62	10.69	8.39	4.14	9.02	8.96	9.87	12.12	13.84	11.77
Net Debt to Equity	22.73	16.55	35.27	-25.65	-26.45	-79.93	-47.97	-45.95	-47.88	-38.7
Net Debt/Capital (%)	17.82	13.65	25.2	10.91	17.23	45.81	34.05	23.38	16.36	12.83
EBITDA	-39	-53	-65	-103	-111	-144	-233	-178	-144	-111
EBITDA-CapEx	-46	-60	-69	-117	-121	-171	-334	-205	-150	-139
Operating Income (Loss)	-44	-58	-71	-109	-118	-153	-249	-207	-176	-136

Liquidity (USD)

API Chat

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	6.44	6.56	4.36	4.55	8.05	7.58	5.57	4.59	3.89	2.54
Current Ratio	6.8	7.16	5.16	5.28	9.29	8.67	6.58	5.79	4.88	3.64
Quick Ratio	6.53	6.81	4.65	4.95	8.78	8.03	6.01	5.19	4.38	3.17
CFO/Avg Current Liab	- -	-5.65	-4.72	-3.6	-4.29	-2.27	-1.62	-1.74	-0.89	-0.59
Common Equity/Total Assets	-105.03	-163	-182.1	-170.34	-114.93	-86.96	-86.17	-133.05	-202.16	-205.59
Long-Term Debt/Equity (%)	- -	- -	- -	2.89	7.8	9.15	10.3	12.7	14.86	13.06
Long-Term Debt/Capital (%)	-14.2	-7.02	-3.59	-1.42	-6.21	-9.71	-11.08	-8.43	-6.07	-4.96
Long-Term Debt/Total Assets (%)	12.83	10.69	6.23	2.35	6.58	7.57	8.45	10.2	11.43	9.62
Total Debt/Equity (%)	-14.59	-6.86	-4.82	5.08	10.7	10.83	12.02	15.09	17.99	15.98
Total Debt/Capital (%)	-16.17	-7.02	-4.83	-2.49	-8.52	-11.49	-12.94	-10.02	-7.35	-6.07
Total Debt/Total Assets (%)	14.62	10.69	8.39	4.14	9.02	8.96	9.87	12.12	13.84	11.77
CFO/Total Liabilities	-25.21	-23.42	-20.86	-251.88	-227.17	-92.55	-72.32	-93.14	-45.25	-28.2
CFO/CapEx	-6.2	-7.78	-17.94	-5.96	-14.42	-4.15	-1.22	-5.13	-12.63	-1.7
Altman's Z-Score	-2.61	-3.68	-3.6	8.06	27.06	24.56	5.19	2.22	7.84	2.99

Working Capital (USD)

API Chat

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	- -	7.42	6.63	6.58	4.89	5.06	6.09	5.81	7.93	8.19
Days Sales Outstanding	- -	49.17	55.09	55.45	74.69	72.18	59.93	62.81	46.05	44.55
Inventory Turnover	- -	15.73	8.2	7.1	6.26	3.66	3.36	4.35	6.4	7.08
Days Inventory Outstanding	- -	23.21	44.54	51.4	58.31	99.8	108.75	83.83	57.04	51.52
Accounts Payable Turnover	- -	9.49	7.01	5.64	9.1	10.15	7.25	8.68	21.89	29.83
Accounts Payable Turnover Days	- -	38.44	52.06	64.76	40.12	35.96	50.35	42.06	16.67	12.23
Cash Conversion Cycle	- -	33.94	47.57	42.09	92.88	136.02	118.33	104.57	86.41	83.83
Inventory to Cash Days	- -	25.96	10.56	4.05	16.38	-27.62	-48.82	-21.02	-10.99	-6.97
Inventories	1	2	6	7	12	32	39	32	24	28
Raw Materials	1	1	3	5	9	19	29	27	17	20
Work In Process	- -	- -	2	1	2	5	3	1	2	2
Finished Goods	- -	- -	1	1	1	8	8	4	5	6
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	- -	- -	- -	656	2,977	5,161	1,899	1,152	2,621	1,683
- Cash & Cash Equivalents	29	31	81	47	94	466	379	286	226	183
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	11	9	10	8	36	63	95	94	85	76
Enterprise Value	-45	-53	-71	525	2,723	4,746	1,489	910	2,430	1,526
Total Capital	-69	-130	-201	-311	-422	-548	-734	-939	-1,157	-1,244
Total Debt/Capital (%)	-16.17	-7.02	-4.83	-2.49	-8.52	-11.49	-12.94	-10.02	-7.35	-6.07
Total Debt / EV	-0.25	-0.17	-0.14	0.01	0.01	0.01	0.06	0.1	0.03	0.05
EV/Sales	- -	- -	- -	9.66	30.22	35.87	7.31	3.71	7.76	4.05
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	- -	656	2,977	5,161	1,899	1,152	2,621	1,683
Diluted Enterprise Value	-17	-22	-71	617	2,920	4,759	1,615	960	2,480	1,576
EV per Share	- -	- -	- -	19.13	69.49	98.37	27.63	16	41.88	25.52
TTM Sales	2	11	25	54	90	132	204	245	313	377
TTM EBITDA	-39	-53	-65	-103	-111	-144	-233	-178	-144	-111
TTM Operating Income	-44	-58	-71	-109	-118	-153	-249	-207	-176	-136
TTM Cash Flow to Firm	-38	-50	-65	-87	-141	-112	-124	-142	-64	-48
TTM Free Cash Flow to Firm	-32	-44	-61	-72	-132	-85	-22	-115	-59	-20

Multiples (USD)

API Chat

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	- -	- -	- -	-8.96	-22.49	-60.59	-84.29	-10.05	-44.41	-85.76
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	-45	-53	-71	525	2,723	4,746	1,489	910	2,430	1,526
Low Price	- -	- -	- -	12.38	18.52	74.25	25.07	11.46	14.42	24.07
EV/Sales	- -	- -	- -	9.66	30.22	35.87	7.31	3.71	7.76	4.05
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	- -	-6.48	-10.42	-39.04	-14.64	-6.13	-10.27	-29.8
Price/Earnings High	- -	- -	- -	-9.17	-22.33	-67.91	-34.62	-11.26	-16.93	-42.61
Price/Earnings Low	- -	- -	- -	-3.16	-5.19	-23.55	-6.2	-3.19	-4.01	-18.53
Price/Book Value	- -	- -	- -	-2.06	-6.49	-8.45	-2.29	-1.12	-2.11	-1.28
Price/Book Value Average	- -	- -	- -	-2.19	-3.18	-9.73	-3.85	-1.21	-1.73	-1.75
Price/Book Value High	- -	- -	- -	-3.1	-6.81	-16.92	-9.11	-2.23	-2.84	-2.51
Price/Book Value Low	- -	- -	- -	-1.07	-1.58	-5.87	-1.63	-0.63	-0.67	-1.09
Price/Tangible Book Value	- -	- -	- -	4.36	8.89	9.56	2.95	2.39	7.04	4.46
Price/Tangible Book Value Average	- -	- -	- -	4.63	4.35	10.99	4.95	2.59	5.76	6.13
Price/Tangible Book Value High	- -	- -	- -	6.56	9.33	19.12	11.72	4.77	9.49	8.77
Price/Tangible Book Value Low	- -	- -	- -	2.26	2.17	6.63	2.1	1.35	2.25	3.82
Price/Sales	- -	- -	- -	12.06	33.04	39	9.33	4.7	8.38	4.47
Price/Sales Average	- -	- -	- -	12.82	16.18	44.88	15.67	5.11	6.85	6.15
Price/Sales High	- -	- -	- -	18.15	34.68	78.05	37.06	9.4	11.29	8.79
Price/Sales Low	- -	- -	- -	6.25	8.06	27.07	6.64	2.66	2.67	3.82
Price/Cash Flow	- -	- -	- -	-7.46	-20.93	-45.98	-15.27	-8.09	-40.9	-35.34
Price/Cash Flow Average	- -	- -	- -	-7.93	-10.25	-52.91	-25.65	-8.8	-33.44	-48.6
Price/Cash Flow High	- -	- -	- -	-11.23	-21.96	-92.02	-60.65	-16.17	-55.12	-69.48
Price/Cash Flow Low	- -	- -	- -	-3.87	-5.1	-31.92	-10.86	-4.58	-13.05	-30.23
Price/Free Cash Flow Average	- -	- -	- -	-9.53	-11.01	-69.72	-141.61	-10.93	-36.32	-117.95
Price/Free Cash Flow High	- -	- -	- -	-13.49	-23.6	-121.26	-334.84	-20.09	-59.87	-168.63
Price/Free Cash Flow Low	- -	- -	- -	-4.65	-5.48	-42.06	-59.97	-5.68	-14.18	-73.36
EV/Sales Average	- -	- -	- -	12.1	15.54	41.83	14.28	4.33	6.4	5.86
EV/Sales High	- -	- -	- -	17.44	34.03	75.01	35.66	8.61	10.84	8.5
EV/Sales Low	- -	- -	- -	5.53	7.42	24.03	5.24	1.87	2.22	3.54
EV/EBITDA Average	0.44	0.41	1.1	-6.41	-12.62	-38.57	-12.5	-5.98	-13.86	-19.81
EV/EBITDA High	0.44	0.41	1.1	-9.23	-27.65	-69.17	-31.22	-11.89	-23.48	-28.74
EV/EBITDA Low	0.44	0.41	1.1	-2.93	-6.02	-22.16	-4.59	-2.59	-4.81	-11.96
EV/EBIT Average	0.4	0.38	1.01	-6.05	-11.91	-36.12	-11.67	-5.13	-11.38	-16.2
EV/EBIT High	0.4	0.38	1.01	-8.71	-26.08	-64.77	-29.15	-10.2	-19.28	-23.5
EV/EBIT Low	0.4	0.38	1.01	-2.77	-5.68	-20.75	-4.29	-2.22	-3.95	-9.78
Last Price	- -	- -	- -	23.88	75.97	106.97	35.24	20.26	45.18	28.14
High Price	- -	- -	- -	35.95	79.72	214.07	139.99	40.5	60.9	55.33
Enterprise Value Average	-17	-22	-71	658	1,400	5,536	2,906	1,061	2,002	2,207
Enterprise Value High	-17	-22	-71	948	3,067	9,926	7,260	2,111	3,392	3,202
Enterprise Value Low	-17	-22	-71	301	668	3,180	1,067	460	695	1,332

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Shares Outstanding	27	27	28	33	45	49	57	58	59	61
Diluted Weighted Avg Shares	19	19	27	27	39	48	54	57	58	60
Basic Weighted Avg Shares	19	19	27	27	39	48	54	57	58	60
Revenue per Share	0.12	0.57	0.96	1.98	2.3	2.74	3.78	4.31	5.39	6.3
EBITDA per Share	-2.1	-2.85	-2.44	-3.74	-2.83	-2.97	-4.31	-3.12	-2.49	-1.86
Operating Income per Share	-2.32	-3.11	-2.65	-3.96	-3	-3.18	-4.62	-3.64	-3.03	-2.28
Basic EPS, GAAP	-2.35	-3.16	-2.68	-3.92	-3.57	-3.15	-4.04	-3.6	-3.6	-1.3
Basic EPS from Cont Ops	-2.35	-3.16	-2.68	-3.92	-3.57	-3.15	-4.04	-3.6	-3.6	-1.3
Diluted EPS, GAAP	-2.35	-3.16	-2.68	-3.92	-3.57	-3.15	-4.04	-3.6	-3.6	-1.3
Diluted EPS from Cont Ops	-2.35	-3.16	-2.68	-3.92	-3.57	-3.15	-4.04	-3.6	-3.6	-1.3
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-2.05	-2.73	-2.49	-3.2	-3.63	-2.33	-2.31	-2.5	-1.1	-0.8
Free Cash Flow per Basic Share	-2.39	-3.08	-2.63	-3.74	-3.88	-2.89	-4.2	-2.99	-1.19	-1.26
Cash & Equivalents per Share	2.98	3.31	3.03	5.03	7.4	9.9	9.37	5.91	4.76	3.89
Book Value per Share	-4.28	-7.43	-7.92	-11.6	-11.7	-12.65	-15.37	-18.16	-21.41	-22.06
Tangible Book Value per Share	-4.2	-7.21	-7.64	5.48	8.54	11.19	11.95	8.49	6.42	6.31

Twist Bioscience Corporation

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)